The Vaccination
Information about supplied vaccines, effectiveness and the vaccination rollouts
Characteristics of COVID-19 Vaccines
COVID-19 vaccines are effective in preventing severe illness and symptoms such as fever or coughs. Vaccination is expected to reduce the number of severe COVID-19 patients and deaths.
Some cases of side effects such as localized pain in the injected site, headache, fatigue, muscle and joint pain, and anaphylaxis (acute allergic reaction) after vaccination in some rare cases have been reported.
Through their pharmaceutical approvals, effectiveness and safety of vaccines for COVID-19 has been verified based on clinical trials and scientific findings.
Available Vaccines
- Pfizer Inc. (approved for people aged 12 years and older)
- Vaccine name: Comirnaty
Vaccine type: mRNA vaccine
Click here
for details of the vaccine - Moderna Inc. * Inoculation ends in mid-February 2023
- Vaccine name: Spikevax
Vaccine type: mRNA vaccine - Pfizer Inc. (approved for children aged 5 to 11 years old)
- Vaccine name: Comirnaty for 5 to 11 years old
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Takeda Pharmaceutical Company Limited（Novavax Inc）
- Vaccine name: Nuvaxovid
Vaccine type: recombinant protein vaccine
Click here for details of the vaccine - Pfizer Inc. (Bivalent)
- Vaccine name: Comirnaty RTU
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Moderna Inc. (Bivalent)
- Vaccine name: Spikevax
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Pfizer Inc. (approved for children aged 6 months to 4 years old)
- Vaccine name: Comirnaty for 6 months to 4 years old
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Pfizer Inc. (Bivalent)(approved for children aged 5 to 11 years old)
- Vaccine name: Comirnaty for 5 to 11 years old
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Pfizer Inc. (XBB)
- Vaccine name: Comirnaty
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Pfizer Inc. (XBB)(approved for children aged 5 to 11 years old)
- Vaccine name: Comirnaty for 5 to 11 years old
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Pfizer Inc. (XBB)(approved for children aged 6 months to 4 years old)
- Vaccine name: Comirnaty for 6 months to 4 years old
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Moderna Inc. (Bivalent)(approved for children aged 6 to 11 years old)
- Vaccine name: Spikevax
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Moderna Inc. (XBB)
- Vaccine name: Spikevax
Vaccine type: mRNA vaccine
Click here for details of the vaccine - Moderna Inc. (XBB)(approved for children aged 6 to 11 years old)
- Vaccine name: Spikevax
Vaccine type: mRNA vaccine
Click here for details of the vaccine
Vaccination rollouts in Japan (by prefecture)
Please refer to here.
Novel Coronavirus Vaccination Q&A Website
We answer the questions about the effectiveness of the novel coronavirus vaccines, their safety, and your eligibility.
